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Abstract
Enterotoxigenic Escherichia coli (ETEC), defined by their elaboration of heat-labile (LT) and/
or heat-stable (ST) enterotoxins, are a common cause of diarrheal illness in developing coun-
tries. Efficient delivery of these toxins requires ETEC to engage target host enterocytes. This
engagement is accomplished using a variety of pathovar-specific and conserved E. coli adhe-
sin molecules as well as plasmid encoded colonization factors. Some of these adhesins
undergo significant transcriptional modulation as ETEC encounter intestinal epithelia, perhaps
suggesting that they cooperatively facilitate interaction with the host. Among genes signifi-
cantly upregulated on cell contact are those encoding type 1 pili. We therefore investigated
the role played by these pili in facilitating ETEC adhesion, and toxin delivery to model intestinal
epithelia. We demonstrate that type 1 pili, encoded in the E. coli core genome, play an essen-
tial role in ETEC virulence, acting in concert with plasmid-encoded pathovar specific coloniza-
tion factor (CF) fimbriae to promote optimal bacterial adhesion to cultured intestinal epithelium
(CIE) and to epithelial monolayers differentiated from human small intestinal stem cells. Type
1 pili are tipped with the FimH adhesin which recognizes mannose with stereochemical speci-
ficity. Thus, enhanced production of highly mannosylated proteins on intestinal epithelia pro-
moted FimH-mediated ETEC adhesion, while conversely, interruption of FimH lectin-epithelial
interactions with soluble mannose, anti-FimH antibodies or mutagenesis of fimH effectively
blocked ETEC adhesion. Moreover, fimH mutants were significantly impaired in delivery of
both heat-stable and heat-labile toxins to the target epithelial cells in vitro, and these mutants
were substantially less virulent in rabbit ileal loop assays, a classical model of ETEC patho-
genesis. Collectively, our data suggest that these highly conserved pili play an essential role
in virulence of these diverse pathogens.
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Author summary
Enterotoxigenic Escherichia coli (ETEC) infections contribute substantially to death and
morbidity due to diarrheal illness and are associated with serious sequelae including mal-
nutrition, stunted growth, and intellectual impairment among young children in develop-
ing countries. Effective engagement of intestinal epithelial cells is essential for ETEC
pathogenicity. Consequently, pathovar specific plasmid-encoded adhesin structures
known as colonization factors (CFs) have been a principal target for vaccines. However,
tremendous inter-strain variation in the carriage of gene clusters encoding different CFs
and significant antigenic diversity of the CF adhesins has posed a challenge to vaccine
development. In contrast, type 1 pili are encoded by the fim operon located in the chro-
mosome of most ETEC strains and are highly conserved. While type 1 pili are known to
play a critical role in virulence of extraintestinal pathogenic E. coli, the present studies rep-
resent the first detailed examination of the contribution of these pili in ETEC pathogene-
sis. Here we demonstrate that ETEC type 1 pili are essential for optimal interactions with
intestinal epithelia and that they play a critical role in virulence. These data may inform
additional approaches toward development of broadly protective vaccines for these patho-
gens of global importance.
Introduction
Among young children under five years of age in developing countries, diarrhea is a leading
cause of morbidity and mortality. Enterotoxigenic E. coli (ETEC) is one of the most common
causes of moderate to severe diarrheal illness and deaths due to diarrhea in young children
and incidentally is also the leading bacterial cause of diarrhea [1]. These bacteria are also a
leading cause of hospitalization due to severe diarrhea in adults in developing countries [2]
and are perennially the predominant cause of diarrheal illness among travelers to the endemic
regions [3, 4]. Additionally, ETEC infections contribute substantially to the burden of diar-
rheal illness associated with sequelae of malnutrition [5, 6], stunted growth [7] and impaired
cognitive development [8]. The effects of ETEC infections also appear to be more critical in
malnourished children [5]. Thus these pathogens contribute to a complex pattern of poverty,
repeated enteric infections, environmental enteropathy [9], and developmental impairment.
ETEC are defined by the production of heat-labile (LT) and/or heat-stable (ST) enterotox-
ins [10], and virulence requires successful delivery of these toxins to cognate receptors on tar-
get intestinal epithelial cells. LT binds to cell surface GM1 gangliosides, and following cellular
entry this toxin activates production of host cAMP; while ST peptides bind guanylate cyclase
C, stimulating production of cGMP [11]. Resulting increases in intracellular concentrations of
these cyclic nucleotides modulate ion channels on the surface of intestinal cells leading to net
losses of sodium chloride and water into the intestinal lumen and ensuing acute watery diar-
rhea [11, 12]. In the classical paradigm of ETEC pathogenesis, these bacteria utilize pathovar-
specific fimbrial or non-fimbrial adhesins, known as colonization factors or CFs [13] which
allow them to adhere and colonize the small intestine where toxin delivery occurs. However,
emerging evidence would suggest that this paradigm is perhaps overly simplistic, and that
there are several potential adhesins which effectively act in concert to promote ETEC engage-
ment of the host [14].
E. coli encode a multitude of pili assembled by the chaperone/usher pathway, termed CUP
pili, which are important in virulence. CUP pili are tipped with specialized adhesins that
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recognize specific receptors with stereochemical specificity. CUP adhesins can determine both
tissue tropism and the course of disease. For example, type 1 pili are encoded by the fim
operon, and chomosomally encoded as part of the core E. coli genome [15, 16]. Type 1 pili are
composite fibers comprised of a pilus rod, made up of FimA subunits arranged in a right
handed helical cylinder [17]. The pilus rod is joined to a fibrillum structure tipped with the
FimH adhesin that binds mannose with stereochemical specificity [16, 18–20]. FimH is critical
for virulence in extraintestinal E. coli, as it has been well-established that FimH mediated adhe-
sion enables uropathogenic E. coli (UPEC) colonization and invasion into bladder epithelial
cells [21–23], as well as the formation of intracellular bacterial communities [24]. ETEC also
encode pathovar-specific CUP pili (fimbriae) like CFA/I [25] that are encoded on virulence
plasmids [26]. More than four decades ago, these ETEC-specific colonization factors were
shown to contribute to development of diarrheal illness in humans [27], and consequently
they have been the subject of intensive investigation and a major focus of ETEC vaccine devel-
opment. Conversely, although early studies described possible type 1 pili expression by ETEC
[28, 29], relatively little is known about the contribution of these highly conserved structures
to virulence. Our more recent observation that the expression of the fim operon is enhanced
by pathogen-host cell contact [14], prompted a thorough investigation of the potential role of
type 1 pili in ETEC pathogenesis reported here.
Results
Type 1 pili promote ETEC binding to intestinal epithelia
Although a number of earlier studies of ETEC suggested that these pathogens make type 1 pili
(also previously referred to as type 1 somatic pili or type 1 fimbriae) [29, 30], to date there has
been no systematic examination of their involvement in ETEC virulence. We therefore first
performed studies to confirm the production of type 1 pili by the prototypical ETEC H10407
strain. Type 1 pili tipped with the FimH adhesin were identified on the surface of strain
H10407 by transmission electron microscopy after immunogold labeling using anti-FimH
antibodies (Fig 1A). Similarly, using flow cytometry we verified production of type 1 pili in
H10407, but not in the corresponding fimH mutant strain (Fig 1B). It has previously been
shown that FimH is required to initiate the assembly of type 1 pili and thus fimH mutants are
nonpiliated [31]. The expression of type 1 pili is under the transcriptional control of an invert-
ible promoter element that governs phase OFF and phase ON populations [32, 33]. Interest-
ingly, mutations that inactivate FimH such as the Q133K mutation, bias the fim promoter
towards the phase OFF state [34]. Thus, compared to the wild type H10407 strain, or pfimH
complemented mutants, isogenic fimH mutants or those complemented with pQ133K, which
encodes FimH with a mutation in the mannose binding site [35], were nonpiliated and incapa-
ble of yeast agglutination, a phenotypic assay for expression of type 1 pili [36] (Fig 1C) and
only the wild type and fimH complemented mutants exhibited demonstrable type 1 pili expres-
sion detected by anti-type 1 pili antibodies in immunoblots (Fig 1D). Next, using polarized
cultured intestinal epithelia (CIE) derived from the C2BBe1 clone of Caco-2 cells which pro-
duce apical brush borders with defined microvilli similar to human intestinal enterocytes [37],
we demonstrated that production of FimH was required for effective adhesion. Mutants lack-
ing fimH were significantly less adherent than wild type ETEC (p<0.0001) (Fig 1E and 1F),
while episomal expression of the fimH gene (pfimH), but not the mutant fimH allele (pQ133K),
restored adhesion. Additionally, H10407-fimH:Q133K, which contains the Q133K mutant
allele of fimH in the chromosome, abrogated yeast agglutination activity and demonstrated sig-
nificant decrease in adhesion to intestinal cells (S1A Fig). Similarly, mutants lacking the fimA
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Fig 1. Type 1 pili expression promotes optimal adhesion of ETEC to intestinal epithelia. a. Transmission
electron micrograph of ETEC H10407 expressing type 1 pili. The FimH tip adhesin was detected using α-FimH
antibody and gold secondary antibody conjugate. b. Flow cytometric analysis of type 1 pili expression by ETEC
H10407 and fimH mutants. c. Assessment of type 1 pili function using yeast agglutination assays. Negative
yeast agglutination reflected the loss of type 1 pili activity. d. FimA immunoblot of type 1 pili extracts from static
culture of WT ETEC, fimH mutants and mutants complemented with wild type fimH gene (pfimH). The fimH
mutant complemented with a plasmid encoding a Q133K substitution in FimH is included as a negative control.
e. Confocal microscopic images showing adhesion of WT ETEC, fimH mutants or complemented mutants to
polarized cultured intestinal epithelia. Bacteria (anti-O78, green), cell membrane (CellMask, red), nuclei (DAPI,
blue). f. Quantitative analysis was done by counting number of bacteria per focus area. Horizontal dashed lines
represent geometric means of 3 combined individual experiments. P values were calculated by nonparametric
Mann-Whitney test. *** indicates p<0.0001.
https://doi.org/10.1371/journal.pntd.0005586.g001
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gene encoding the major type 1 pili pilin subunit exhibited loss of functional type 1 pili in
yeast agglutination assays, resulting in significant reduction of adhesion to the CIE (S1B Fig).
Inhibition of type 1 pili mediated interactions reduces ETEC adhesion
We found that methyl-α-D-mannose but not the methyl-α-D-galactose control sugar, inhib-
ited FimH mediated yeast agglutination by ETEC (Fig 2A) and ETEC adhesion to epithelial
cells (Fig 2C). Similarly, antibodies generated against the lectin domain of FimH (α-FimH),
but not control antibodies, separated from pre-immune sera, inhibited FimH mediated yeast
agglutination with wild type bacteria expressing type 1 pili (Fig 2B) and significantly inhibited
ETEC adhesion to intestinal cells (Fig 2D). Collectively, these data support the idea that ETEC
utilize type 1 pili to engage intestinal epithelia.
ETEC FimH adhesin binds to intestinal epithelia
We next examined the ability of the FimH tip adhesin to directly engage the intestinal epithe-
lial surface. The purified lectin domain of FimH (FimHLD, 17 kD), representing amino acid
residues 1–154 of mature FimH, bound to the apical surface of the CIE. In contrast, binding of
FimHLD:Q133K, which lacks mannose binding activity, was markedly diminished (Fig 3A
and 3B) as was binding of the wild type FimHLD protein in the presence of exogenous man-
nose (Fig 3B).
ETEC are noninvasive luminal pathogens thought to engage the microvilli at the apical sur-
face of intestinal epithelial cells. Presumably, the FimH lectin can promote this engagement by
Fig 2. Inhibition of type 1 pili mediated interaction impairs ETEC adhesion. Yeast agglutination assay of
WT ETEC (a) is inhibited by methyl-α-D-mannose (man) but not equimolar concentrations of methyl-α-D-
galactose (gal) control sugar. b. Anti-FimH antibodies, generated against the lectin domain of FimH, but not
pre-immune sera inhibit yeast agglutination. c. In vitro adhesion of WT ETEC or fimH mutants in the absence
or presence of methyl-α-D-galactose or methyl-α-D-mannose. d. WT ETEC adhesion is inhibited by anti-
FimH antibodies. The percentage of cell associated bacteria represents the proportion of bacteria associated
with the CIE at the end of 1 h relative to the inoculum. Bars represent mean values + SEM (n = 5). P values
were calculated by nonparametric Mann-Whitney test. * indicates p<0.05.
https://doi.org/10.1371/journal.pntd.0005586.g002
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interacting with mannosylated glycoconjugates on the glycocalyx covering the microvilli.
Indeed, using transmission electron microscopy, we identified FimH by immunogold labeling
at the ETEC-microvillus interface (Fig 3C).
Surface mannosylation enhances FimH-mediated ETEC-epithelial
interaction
Because FimH interacts with mannosylated receptors on the epithelial surface, we examined
the impact of enhanced glycoprotein mannosylation on ETEC pathogen host interactions. Fol-
lowing CIE treatment with kifunensine, an α-mannosidase class 1 enzyme inhibitor which
enhances the display of high-mannose glycoproteins [38], we observed a significant increase in
FimHLD binding (Fig 4A and 4B). Likewise, WT ETEC adhesion to the kifunensine treated
CIE was enhanced relative to the untreated control CIE (p<0.0001) (Fig 4C and 4D). How-
ever, kifunensine treatment had no impact on adhesion of the fimH mutant. These data further
Fig 3. FimH adhesin of ETEC interacts with intestinal epithelial cells. a. Confocal microscopy images show binding of the
biotinylated FimH lectin domain (FimHLD) or FimHLD:Q133K to the apical surface cultured intestinal epithelium (CIE). Biotinylated
FimHLD was detected with streptavidin-conjugated fluorescent nanocrystals (Qdot, green); plasma membranes were stained with
CellMask (red) and nuclei with DAPI (blue). Image at right shows three dimensional reconstruction of z stacks of CIE following
interaction with FimHLD or the mutant protein. b. Quantitative analysis of FimHLD binding to CIE represented in panels a using
Volocity three-dimensional (3D) image analysis software (version 6.2; PerkinElmer, Inc.). P value was calculated using nonparametric
Mann-Whitney testing. c. Immunoelectron microscopy images of CIE infected with ETEC H10407. Left panel, microvilli structure at
the apical surface of the CIE; right panels show immunogold labeling of FimH localized to the ETEC-host interacting surface.
https://doi.org/10.1371/journal.pntd.0005586.g003
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suggested that availability of mannosylated glycoproteins on the host cell surface promotes
ETEC adhesion through FimH.
Type 1 pili act in concert with CFA/I fimbriae for optimal adhesion
Because ETEC H10407 expresses both type 1 pili and plasmid encoded CFA/I fimbriae specific
to the ETEC pathovar, we investigated whether these CUP structures acted cooperatively in
facilitating adhesion to intestinal epithelia. The CFA/I fimbriae are encoded by the cfaABCE
operon in which cfaE encodes the CfaE tip adhesin [26, 39, 40]. Interestingly, mutations in
either fimH or cfaE significantly reduced adherence of ETEC compared to wild type H10407,
suggesting that both pili participate in ETEC adhesion (S2 Fig). Mutants lacking both the type
1 pili and the CFA/I tip adhesin genes (fimH-cfaE) demonstrated further reduction in adhesion
compared to either of the single mutants (S2 Fig). Although additional data are needed to
define the precise respective contributions of the chromosomally encoded type 1 pili and the
plasmid encoded pathovar specific CFA/I, these initial data support our hypothesis that the
structures act in concert to facilitate adhesion.
Type 1 pili mediate adhesion to human small intestinal enteroids
While the CIE used in this study possess some features of normal intestinal epithelial cells,
they are derived from metastatic colon cancer cells which fail to represent the diversity of cell
types present in intestinal epithelium. Enteroids, derived from human intestinal stem cells col-
lected from healthy volunteers [41–43], can recapitulate many aspects of normal physiology
and preserve features of human intestinal epithelium. These include presentation of different
cell types including enterocytes, goblet cells, Paneth cells, and endocrine cells [44–46]. There-
fore, to further assess the contribution of type 1 pili in ETEC adhesion to intestinal epithelia
we established polarized intestinal epithelial monolayers derived from ileal specimens obtained
from normal adult human subjects. In these enteroid-derived monolayers we were able to
identify enterocytes with a defined brush border and distinct microvilli on the apical surface as
well as goblet cells, and chromogranin A positive cells suggesting that they faithfully reproduce
many features of surfaces normally presented to bacteria within the intestine (Fig 5A–5E).
Similar to our studies of CIE, we found that wild type ETEC adhered to the surface of stem
cell derived polarized small intestinal (ileal) monolayers (Fig 6A and 6B) in close approxima-
tion with the microvillus surface (Fig 6C), and that mutation of fimH significantly attenuated
adherence relative to the wild type parent strain (Fig 6D). Wild type bacteria adhered well to
polarized monolayers of enteroid collected from multiple individuals, while the fimH mutant
was persistently deficient in its ability to adhere to all target epithelia relative to the parent
strain (Fig 6E). These studies suggested that type 1 pili of ETEC potentially play an important
role in specifically directing bacterial interaction with the small intestine where release of tox-
ins is thought to provoke the efflux of water and salt that lead to diarrhea.
Type 1 pili promotes optimal toxin delivery to intestinal cells in vitro
Close contact of ETEC with target epithelial cells is essential for efficient delivery of its entero-
toxins [47, 48]. To investigate the impact of type 1 pili mediated ETEC-host interactions on
toxin delivery, we measured the intracellular production of cAMP and cGMP, cyclic nucleo-
tide second messenger markers for delivery of LT and ST, respectively, in infected cells. cAMP
and cGMP was significantly increased in target cells infected with WT H10407 relative to fimH
or fimA mutants (Fig 7A and 7B). Methyl-α-D-mannose significantly reduced levels of intra-
cellular cGMP and inhibited cAMP activation in target cells infected with WT H10407 (Fig 7A
and 7B). These effects were observed despite wild type levels of heat-labile toxin being
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produced by the mutants (Fig 7C). Together, these data suggested that type 1 pili are required
for optimal delivery of both heat-labile and heat-stable enterotoxins to the target epithelial
cells.
Type 1 pili are required for ETEC virulence
We next examined the contribution of type 1 pili to pathogenesis in the rabbit ileal loop
model, a classical model of virulence for V. cholerae and ETEC [49]. Both fimH and fimA
mutants were significantly less adherent than the WT H10407 to rabbit ileal intestinal
Fig 4. Enhanced presentation of mannosylated glycoproteins increases FimH binding and ETEC adhesion.
a. Confocal microscopy images detecting FimHLD binding to the kifunensine treated CIE. Biotinylated FimHLD was
detected with streptavidin-conjugated fluorescent nanocrystals (Qdot, green) and nuclei with DAPI (blue). b. Qu-
antitative analysis of FimHLD binding to CIE represented in panels a using Volocity three-dimensional (3D) image
analysis software (version 6.2; PerkinElmer, Inc.). Data represent mean ± standard deviation of results of 3 inde-
pendent experiments each with triplicate wells per concentration tested (n = 9). c. Confocal microscopic images
showing ETEC adhesion to kifunensine treated CIE. The CIE grown on trans-well filters were treated with kifunen-
sine and infected with WT ETEC or fimH mutants. One hour post infection wells were processed for microscopic
examination. Bacteria (green), cell membrane (red), DAPI (blue). d. Quantitative analysis was done by counting
number of bacteria present per focus area. Horizontal dashed lines represent geometric mean of 25 total data
points combined from 2 replicate experiments. P values were calculated by nonparametric Mann-Whitney test.
*** indicates p<0.0001.
https://doi.org/10.1371/journal.pntd.0005586.g004
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epithelium (Fig 8A and 8B). Likewise, while considerable fluid accumulation, a hallmark of
ETEC virulence, was observed in loops infected with WT H10407 (Fig 8C) no demonstrable
fluid accumulation was observed in control loops infected with eltAB mutants [47] which do
not make LT toxin (S1 Table), or those containing only PBS, and we detected significantly less
fluid accumulation in the loops infected with either the fimH or fimA mutants (Fig 8C), sug-
gesting that type 1 pili mediated pathogen-host interactions contribute to ETEC virulence in
this model.
Fig 5. Properties of human enteroid-derived small intestinal monolayers. a. Hematoxylin and eosin
staining, DIC, and UEA1 lectin immunofluorescence confocal microscopic images showing formation of
continuous monolayers. The apical surface is detected in the bottom image with FITC conjugated UEA1 lectin.
b. UEA1 and anti-villin 1 antibody immunofluorescence in Laser Scanning Confocal Microscopy (LSCM)
images from sections of polarized small intestinal enteroid monolayers. Nuclei (DAPI) are shown in blue. c.
LSCM of sections showing MUC2 immunofluorescence (red) in probable goblet cell and co-localization with
UEA1 in the merged image. d. Chromogranin A positive cells (red). e. Transmission electron microscopy
(3000x) of polarized small intestinal enteroid monolayer sections showing a goblet cell flanked by enterocytes
with distinct microvilli on the apical surface. Transwell filters in sections are indicated by *.
https://doi.org/10.1371/journal.pntd.0005586.g005
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Type 1 pili are highly conserved in diverse clinical ETEC isolates
To investigate the prevalence of functional type 1 pili expression in clinical ETEC isolates, we
tested 174 geographically and phylogenetically disparate clinical isolates including recently
Fig 6. Type 1 pili are required for optimal adhesion to small intestinal epithelia. a. Representative laser scanning confocal
microscopy (LSCM) images of sections prepared from human small intestinal enteroid-derived polarized monolayers infected
with WT H10407 (red, anti-O78). Surface staining with the UEA1 lectin is shown in green. Nuclei are stained in blue (DAPI). b.
Three dimensional reconstruction of LSCM z stacks of ETEC H10407 infected polarized monolayers showing the distribution of
zonula occludens-1 (ZO-1, green) at the apical surface. Bacteria were visualized with anti-O78 (red) and nuclei are stained with
DAPI (blue). c. Transmission electron microscopy images of ETEC H10407 adhering to microvilli on the surface of small
intestinal monolayers (magnification 7500x and 15000x for left and right images respectively). d. LCSM images of wild type (wt)
versus fimH mutant bacteria adherent to the surface of small intestinal enteroids Bacteria were visualized with anti-O78 (green)
and cell membranes with CellMask (red), nuclei (DAPI, blue). e. Quantitative analysis of ETEC adhesion to enteroid-derived
monolayers represented in panel d. Each dot plot represents adhesion data obtained using ileal cell derived from two individual
subjects. Horizontal lines represent geometric means of data combined from 2 independent experiments. P values were
calculated by nonparametric Mann-Whitney testing.
https://doi.org/10.1371/journal.pntd.0005586.g006
Fig 7. Type 1 pili mediated interactions enhance toxin delivery. a. Quantification of intracellular cGMP in infected cells. Cells were
infected with WT ETEC in the absence or presence mannose sugar or with fimH or fimA mutants. Cells infected with estH/estP mutants which
lack production of both heat stable toxins ST-H (ST-1b) and ST-P (ST-1a), represent basal level of cGMP in cells. b. Quantification of the
amount of intracellular cAMP in infected cells. Cells were infected with WT ETEC in the absence or presence mannose sugar or with fimH or
fimA mutants. Cells infected with eltAB, LT mutants, represent basal level of cAMP in cells. c. LT secretion by different mutants. Each bar
represent mean with SEM (error bar) of 2 experiments consisting of 5 replicates per experiment for each strain. All P values were calculated
by nonparametric Mann-Whitney test. *** p<0.0001.
https://doi.org/10.1371/journal.pntd.0005586.g007
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sequenced [50] strains using yeast agglutination assays. Overall, the majority (76%) of the
clinical isolates demonstrated yeast agglutination activity indicative of preserved functional
type 1 pili expression among ETEC. Importantly, we observed type 1 pili expression in iso-
lates possessing each of the major colonization factors (CFs), and in 82% of isolates without
any recognizable CFs (Table 1). Overall, these data suggest that functional type 1 pili are
highly conserved in diverse ETEC clinical isolates.
Collectively data presented here provide evidence that type 1 pili play an essential role in
the pathogenesis of these highly diverse pathogens. Similar to their well-established role in the
pathogenesis of uropathogenic E. coli (UPEC) [51] where type 1 pili are required for interac-
tion with bladder epithelia, these structures appear to be highly conserved in clinical isolates
and appear to be critical for ETEC adhesion and effective engagement of host intestinal epithe-
lia that are ultimately required for efficient delivery of effector molecules including the known
toxins.
Discussion
Enterotoxigenic E. coli are a remarkably diverse group of pathogens that share plasmid-
encoded effector molecules, namely heat-labile toxin (LT) and/or heat-stable toxins (ST). In
effect, ETEC pathogenesis can be summarized by the virulence features that collectively facili-
tate the delivery of these toxins [52]. Successful engagement of the complex landscape pre-
sented by the intestinal mucosae that includes a secreted mucus layer as well as the glycocalyx,
glycoconjugates on the apical surface of the epithelium [53, 54], represents an essential step in
ETEC virulence. Like other enteric pathogens, ETEC appear to employ a number of different
adhesins (lectins) that recognize specific carbohydrate moieties on intestinal epithelia [55–58].
While most studies of ETEC adhesion, and consequently vaccine development, had previ-
ously focused on plasmid-encoded colonization factors, recent studies have suggested that
Fig 8. Type 1 pili are required for virulence in the rabbit ileal loop assay. Type 1 pili are required for optimal bacterial engagement of rabbit
intestinal epithelia. a. sections of rabbit ileum in which attached bacteria (green) are identified with anti-O78 (top panel) or anti-FimH (bottom panel).
Nuclei are stained with DAPI (blue) and membranes are stained with CellMask (red). b. bacteria adherent to the ileal mucosal surface following
infection with wild type ETEC H10407 or fimH and fimA mutants. c. Type 1 pili are required for toxicity in the rabbit ileal loop assay. Shown in the
graph is the amount of fluid accumulation in each loop infected with WT or fimH or fimA mutants 18 h post inoculation. Loops infected with eltAB
mutants or mock infected (PBS) were used as controls. Data represent the summary of experiments from 7 different rabbits (n = 7). Inset image
shows infected ileal loops from one representative experiment. Each loop in the inset image is labeled with the infecting bacterial strain or with the
negative control (PBS).
https://doi.org/10.1371/journal.pntd.0005586.g008
Type 1 pili promote ETEC pathogen-host interactions
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0005586 May 22, 2017 11 / 23
bacterial adhesion, intestinal colonization, and toxin delivery ultimately represent very com-
plex phenotypes involving the orchestrated deployment of a variety of pathovar specific plas-
mid encoded adhesins [14, 59, 60] as well as highly conserved chromosomally-encoded
molecules [61] and other virulence factors including mucinases [62, 63]. Although a number
of early studies had suggested that ETEC have the capacity to make type 1 pili [30, 64], their
contribution to pathogenesis had not been comprehensively investigated.
Here, we demonstrate convincingly that most ETEC make type 1 pili, that these organisms
utilize these highly conserved pili to engage model intestinal epithelia, where these interactions
are critical for effective delivery of both heat-labile and heat-stable toxins. Additionally, our
data demonstrate that type 1 pili act in concert with the plasmid-encoded pathovar specific
colonization factors to promote optimal interaction of H10407 with host intestinal epithelial
Table 1. Relationship of functional type 1 pili expresion to colonization factors.
CF designation(s) CF expression Type 1 fimbrial
expressiona
number % number %
CFA/I, CS21 28 16 26 93
CS1, CS3, CS21 15 8.6 2 13
CS7 14 8 14 100
CS2, CS3, CS21 11 6.3 10 91
CS5, CS6 9 5.2 9 100
CFA/I 7 4 7 100
CS1, CS3 6 3.4 2 33
CS21 6 3.4 2 33
CS17 5 2.9 5 100
CS20, CS21 5 2.9 5 100
CS4, CS6 5 2.9 1 20
CS2, CS3 4 2.3 2 50
CS14 3 1.7 2 67
CS6, CS21 3 1.7 3 100
CS1 2 1.1 2 100
CS1, CS3, CS20, CS21 2 1.1 0 0
CS6 2 1.1 2 100
CS6, CS20, CS21 2 1.1 2 100
CS6, CS8 2 1.1 2 100
CFA/I, CS20, CS21 1 0.6 1 100
CS1, CS21 1 0.6 0 0
CS12, CS20 1 0.6 1 100
CS12, CS20, CS21 1 0.6 1 100
CS19 1 0.6 1 100
CS2, CS3, CS20 1 0.6 1 100
CS2, CS3, CS20, CS21 1 0.6 0 0
CS5 1 0.6 1 100
CS5, CS6, CS21 1 0.6 1 100
Undetected 34 19.5 28 82
total + isolates 140b 80 133 b 76
a determined by mannose-sensitive yeast agglutination.
b of n = 174 total isolates queried
https://doi.org/10.1371/journal.pntd.0005586.t001
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surfaces. The precise interactions between type 1 pili and the host cell surface have not been
thoroughly delineated, however, the data included here support the involvement of the minor
pilin tip adhesin subunit (FimH) in mannose-dependent engagement of one or more host cell
receptors [65–68].
Before the advent of recombinant techniques to construct isogenic deletion mutants, earlier
investigations of ETEC H10407-P, a plasmid-cured strain of H10407 which lacks the large vir-
ulence plasmid encoding CFA/I colonization factor, Knutton et. al. suggested that type 1 pili
mediated ETEC adhesion to human intestinal biopsies in a fashion that was inhibited by exog-
enous mannose [28, 29]. However, it was suggested that these pili were mediating adhesion to
the basolateral surface of enterocytes rather than the apical side [28]. The data presented here
overcome many of the technological limitations inherent in these earlier studies and demon-
strate convincingly that type 1 pili mediate adhesion of ETEC to apical surface of small intesti-
nal enterocytes, where LT and ST bind to surface GM-1 and guanylate cyclase C receptors,
respectively.
The present studies raise important questions regarding the nature of type 1 pilus produc-
tion by ETEC including how these structures might work cooperatively with canonical coloni-
zation factor fimbriae, and whether ETEC might encode FimH variants[69, 70] that favor
colonization of the small intestine. Addressing these issues could be relevant to understanding
how type 1 pili might be targeted in vaccines.
While ETEC cause a tremendous burden of disease in low-middle income countries, and
among travelers to these regions, at present, there is no suitable broadly protective vaccine to
prevent infections caused by ETEC. This in part relates to substantial genetic and antigenic
heterogeneity within the enterotoxigenic Escherichia coli pathovar. Most vaccines to date, in
some form, have targeted the plasmid encoded colonization factor antigens. The remarkable
heterogeneity of these antigens [71] and the fact that many ETEC [72, 73], more than half of
isolates in some studies [74], do not make a recognizable colonization factor have prompted
further investigation of these pathogens to define additional vaccine target antigens [75]. Our
observation that ETEC isolates from a phylogenetically and geographically diverse collection
of strains express functional type 1 pili can potentially inform alternative approaches to design
of broadly protective immunogens.
In summary, the data presented here demonstrate that ETEC utilize type 1 pili for optimal
engagement of the host intestinal epithelium and that these interactions facilitate toxin deliv-
ery to the target enterocytes essential for virulence. These studies provide an expanded view of
ETEC molecular pathogenesis beyond the canonical paradigm envisioned more than 40 years
ago, and potentially afford new avenues for the rational design of strategies to prevent the
global burden of disease associated with these important pathogens.
Methods
Mutagenesis and cloning
Isogenic fimH and fimA mutants (S1 Table) were constructed using lambda red mediated
recombination as previously described [76].To construct the fimH mutant primers jf101413.7
and jf101413.8 (S2 Table) were used to amplify the kanamycin resistance cassette from pKD4
plasmid with 60-bp tails corresponding to the DNA sequence immediately upstream and
downstream of fimH. The resulting amplicon was then introduced into H10407 carrying the
pKD46 helper plasmid for lambda red-mediated homologous recombination and mutants
were selected on 50 μg/ml Kanamycin containing LB-agar plate, and tested for loss of fimH
gene by PCR using primers jf120913.9 and jf120913.10. A complementation plasmid (pfimH)
was constructed by amplifying the fimH gene with its native stop codon using primers
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jf120814.1 and jf120814.2 and cloning into pFLAG-CTC plasmid using infusion cloning kit
(Clontech, Takara Bio, USA). A fimA complementation plasmid was constructed by cloning
the fimA gene from H10407 into the EcoR1 and BamH1 sites of pTrc99A[77]. Site-directed
mutagenesis of pfimH with primers jf031814.1 and jf031814.2 was used to change the CAA
codon corresponding to the glutamine residue at position 133 of FimH to AAA codon corre-
sponding to the lysine residue resulting in pQ133K (QuikChange, Stratagene, USA). Plasmids
pfimH and pQ133K (S3 Table) were then introduced into the fimH mutants for complementa-
tion. All mutants were checked for motility, growth and secretion of known effector molecules
including LT, EtpA and EatA.
To construct an expression plasmid for polyhistidine tagged FimH lectin domain
(FimHLD), we amplified the N-terminal lectin region of fimH gene using primers jf042314.1
and jf042314.2. The amplicon was then cloned into pETDUET1 (In-Fusion, Clontech). Site
directed mutagenesis was used to generate the mannose binding deficient FimHLD:Q133K as
described above. The resulting plasmids, pfimHLD and pfimHLD:Q133K, were then intro-
duced into BL21 (DE3) pLys strain for expression and purification of polyhistidine-tagged
FimHLD and FimHLD:Q133K.
Expression and purification of recombinant protein
Overnight cultures of BL21 (DE3) pLys containing pfimHLD or pfimHLD:Q133Kwere diluted
1:100 into 2 liters of terrific broth supplemented with 100 μg/ml ampicillin and grown for 3 h
at 37˚C to optical density of ~0.7 at a wavelength of 600 nm (OD600) then induced with 1 mM
IPTG for 3 h at 30˚C. Cells were harvested, lysed and his-tagged proteins were purified from
the bacterial lysates by nickel affinity chromatography using HisTrap HP column (GE health-
care bioscience, PA, USA). His-tagged FimHLD and FimHLD:Q133K were further purified by
size exclusion column chromatography using HiLoad16/600 Superdex 200 pg column (GE).
Antibody generation and purification
Anti-FimH polyclonal rabbit antiserum was produced against the lectin domain of FimH as
previously described [61]. Briefly, two New Zealand White rabbits were immunized (Rock-
land, USA) with recombinant polyhistidine-tagged FimHLD. Antibodies were separated from
serum components using HiTrap columns prepacked with protein G Sepharose (GE). The
resulting polyclonal antibodies were then pre-absorbed using lyophilized strain AAEC191-A
[15], and affinity purification of antibody against FimHLD immobilized on nitrocellulose was
performed as previously described [61, 78].
Bacteria and cell culture
All experiments were carried out using prototypical ETEC strain H10407[79] or the isogenic
mutants (S2 Table). Bacteria were grown at type 1 pili inducing conditions by following static
incubation for 24 h at 37˚C followed by subculturing at 1:100 for additional 24 h statically at
37˚C [34] in LB media supplemented with or without antibiotic, as appropriate, unless other-
wise stated. C2BBe1 cells (ATCC Accession Number CRL-2102), a subclone of the Caco-2 cell
colonic adenocarcinoma line, was used for generation of the cultured intestinal epithelium
(CIE). In order to generate polarized monolayers which form an apical brush border, with
microvilli morphologically comparable to that of the human intestinal epithelium [37], we
seeded ~2 x105 C2BBe1 cells onto Transwell filters (0.4μM polystyrene membrane, 6.5mm
diameter insert) in DMEM media supplemented with 10% FBS and 10 μg/ml human transfer-
rin (Lonza, MD, USA) and grew at 37˚C with 5% CO2 for three weeks for CIE (polarized
monolayer culture). Media were changed every 2–3 days. Formation of microvilli was verified
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by transmission electron microscopy. Caco-2 cells (ATCC) were cultured in MEM media sup-
plemented with 20% FBS. T-84 (ATCC) cells were cultured in DMEM/F12 (1:1) media supple-
mented with 5% FBS.
Flow cytometry
Strains grown under type 1 pili inducing conditions were processed for flow cytometric analy-
sis. For surface staining, bacterial pellets were washed once with PBS, fixed in 2% paraformal-
dehyde for 15 min and then incubated with 1%BSA in PBS for 30 min at RT. Bacteria were
then incubated with primary antibody (α-FimH) at RT for 45 min. After washing with PBS,
secondary antibody staining was performed at RT in the dark with species-specific antibodies
conjugated with AlexaFluor 546 for an additional 45 min. Bacteria were then washed with PBS
and resuspended in 100 μl of PBS for acquisition by flow cytometry (FACSCalibur, BD Biosci-
ences). A minimum of 50,000 organism counts were acquired (CellQuest software, Becton
Dickinson), and subjected to subsequent analysis (FlowJo, v7.6.3).
Type 1 pili extract preparation and detection
Type 1 pili were extracted by following a previously described method with some modifica-
tions [80]. Briefly, bacteria grown in type 1 pili inducing conditions were harvested, re-sus-
pended in 1 ml of 1 mM Tris-HCl (pH 8.0) and incubated at 65˚C for 1 h with occasional
vortexing and pelleted by centrifugation (15,000 × g for 5 min). The supernatant was then
transferred to another tube, and an aliquot was precipitated in salt (300 mM NaCl and 100
mM MgCl2) by incubating overnight at 4˚C, followed by centrifugation at 20,000 × g for 10
min at 4˚C. The protein pellet was re-suspended in 1 mM Tris-HCl (pH 8.0). Fimbrial extracts
were separated by sodium dodecyl sulfate (SDS)-15% polyacrylamide gel electrophoresis mini-
gels (Bio-Rad). Proteins were either stained with Coomassie brilliant blue or transferred to
nitrocellulose membranes (Bio-Rad) using a Mini Trans-Blot electrophoretic cell (Bio-Rad)
for 60 min at 100 V. The membrane was blocked with 5% milk-PBS supplemented with 0.05%
Tween 20 (Pierce). Incubations with primary (1:5,000) and secondary (1:5,000) antibodies
were carried out for 1 h at RT. Chemiluminescent substrate (Clarity Western ECL substrate,
Bio-Rad) was used for detection.
Yeast agglutination assay
Yeast agglutination as a phenotypic test for the production of type 1 pili [36], was performed
using the following conditions: strains to be tested were grown in 1 ml Luria broth at type 1
pili inducing conditions, harvested and adjusted to OD600 of 1.0 in PBS. Agglutination was
performed on glass slides by mixing 20 μl bacteria with an equal volume of bakers’ yeast sus-
pension adjusted to OD600 of 1 in PBS.
Adhesion assays
For adhesion assays, bacteria to be tested were grown at type 1 pili inducing conditions and
diluted at 1:10 in pre-warmed cell culture media prior to infection. Serial dilutions of each
inoculum were plated on Luria agar for CFU count. Infected CIE were incubated at 37˚C and
5% CO2 for 1 h, washed with pre-warmed tissue culture medium 3 times with gentle shaking
(100 rpm) for 1 min each. The CIE were then either lysed in 0.1% Triton X-100 for 5 min, and
the cell associated bacteria were recovered by plating lysates onto Luria agar, or processed for
fluorescence microscopy for enumeration of bacteria attached to the cells.
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Fluorescence microscopy
To investigate the binding of FimH in the context of intestinal epithelial cells, 100 μl of 50 μg/ml
biotinylated FimHLD or FimHLD:Q133K were incubated with CIE. After an hour of incuba-
tion at 37˚C unbound FimHLD were washed off with tissue culture media, the cells were fixed
with 2% paraformaldehyde for 30 min at room temperature (RT), washed twice with PBS, and
blocked with 1% BSA-PBS for another 30 min at RT. Streptavidin coated Qdot 594 was then
used at 1:100 dilution in 1% BSA-PBS to detect biotinylated FimHLD bound to the cell surface.
For detection of ETEC adhesion, infected CIEs were incubated with anti-O78 antibody followed
by fluorescent labeled secondary. Cell membranes and nuclei were stained as previously
described (CellMask, red for membrane and DAPI for nuclei; Invitrogen) [61]. Images were
acquired on a Zeiss LSM510 confocal microscope, and files were converted to TIFF image using
ImageJ (v1.45). Signals were quantified using Volocity software (version 6.2; PerkinElmer, Inc.).
Transmission immunoelectron microscopy
For localization of FimH on intestinal epithelium, ETEC infected CIE were fixed in 2% para-
formaldehyde/0.02% glutaraldehyde (Polysciences Inc., Warrington, PA) in 100 mM PIPES/
0.5 mM MgCl2, pH 7.2 for 1 h at 4˚C. Samples were washed with PIPES buffer, blocked with
5% Fetal Bovine Serum /5% Normal Goat Serum for 20 min and subsequently incubated with
rabbit anti-FimH antibody for 1 h, followed by secondary goat anti-rabbit antibody conjugated
to 18 nm colloidal gold for 1 h. Samples were washed in buffer and postfixed in 1% osmium
tetroxide (Polysciences Inc.) for 1 h. Samples were then rinsed extensively in dH2O prior to en
bloc staining with 1% aqueous uranyl acetate (Ted Pella Inc., Redding, CA) for 1 h. Following
several rinses in dH2O, samples were dehydrated in a graded series of ethanol and embedded
in Eponate 12 resin (Ted Pella Inc.). Sections of 95 nm were cut with a Leica Ultracut UCT
ultramicrotome (Leica Microsystems Inc., Bannockburn, IL), stained with uranyl acetate and
lead citrate, and viewed on a JEOL 1200 EX transmission electron microscope (JEOL USA
Inc., Peabody, MA) equipped with an AMT 8 megapixel digital camera (Advanced Microscopy
Techniques, Woburn, MA).
Growth and differentiation of human small intestinal epithelial cells
Enteroids were grown as previously described in detail [45] from purified intestinal cell lines,
maintained at the Washington University Digestive Diseases Research Core Center BioSpeci-
mens Core under a protocol approved by the Institutional Review Board. Briefly, cells were
thawed and re-suspended in Matrigel (BD Biosciences, San Jose, CA, 15 μL/well in 24 well
plates), and incubated at 37˚C with a 1:1 mixture of L-WRN conditioned media (CM) and pri-
mary culture media (Advanced DEM/F12, Invitrogen) supplemented with 20% fetal bovine
serum (FBS), 2 mM L-glutamine, 100 units/mL penicillin, 0.1 mg/mL streptomycin, 10 μM Y-
27632 (ROCK inhibitor; Tocris Bioscience, R and D Systems, Minneapolis, MN), and 10 μM
SB 431542 (transforming growth factor-ß type 1 receptor inhibitor; Tocris Bioscience, R and
D Systems). For polarization, cells were added to Transwell filters (Corning) and incubated in
differentiation media (1:20 mixture of L-WRN CM and primary culture media) lacking SB
431542. Cells were grown to confluence for 3 days in differentiation media before use.
Histological analyses of eneteroid-derived human intestinal epithelial
monolayers
For histological analysis (Day 3), enteroids grown on transwell were fixed in 3.7% paraformal-
dehyde (Electron Microscopy Sciences, Hatfield, PA) for 15 min, washed once with PBS and
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processed for paraffin embedding. Transverse sections (5 μm) were stained with hematoxylin
and eosin (visualized with a Zeiss Axioskop 2 MOT microscope fitted with a CRI Nuance FX
multispectral imaging system, Cambridge Research and Instrumentation), or used for immu-
nostaining. For immunostaining, sections were de-paraffinized and hydrated, boiled in
Unmasking Solution (Vector Laboratories, Burlingame, CA) for 25 min, rinsed in PBS,
blocked in 1% bovine serum albumin/0.1% Triton-X100 for 30 min and incubated with pri-
mary antibody at 4˚C overnight. Primary antibodies included rabbit anti- ChgA (1:100,
Abcam, Cambridge, MA), rabbit anti-Muc2 (1:100, Santa Cruz Biotechnology, Inc., Dallas,
Texas), mouse monoclonal anti-Villin 1 (1:100; Santa Cruz Biotechnology, Inc.). Slides were
rinsed 3 times with PBS and incubated for 60 min at RT with species specific secondary anti-
bodies (1:200; Invitrogen) conjugated to AlexaFluor488 or AlexaFluor546. For detection of
bacteria, enteroids (grown for 3 days) were infected for 1 h, washed 3 times with pre-warmed
media, fixed in 3.7% paraformaldehyde and either processed for fluorescent microscopy or
embedded in paraffin. For the detection of tight junction formation, antibody against zonula
occludens-1 (anti-ZO-1, mouse monoclonal, Invitrogen) was used at 1:100 dilutions followed
by anti-mouse secondary antibodies conjugated to AlexaFluor488 (1:200, Invitrogen). Paraffin
embedded sections were deparaffinized and processed for immunostaining with anti-O78
antibody (1:200) followed by secondary antibodies (1:200; Invitrogen) conjugated to Alexa-
Fluor 546 for the detection of cell associated bacteria. UEA-1 lectin conjugated to FITC (1:100,
Sigma) was applied during secondary antibody incubation. Slides were washed 3 times in PBS
and stained with DAPI (Molecular Probe) to visualize nuclei and cellmask red (1:2000, Invitro-
gen) to visualize plasma membrane and mounted with ProlongGold antifade reagent (Molecu-
lar Probes) for confocal microscopy (Nikon ECLIPSE Ti confocal microscope equipped with
NIS-Elements imaging software). To examine ETEC association with microvilli of polarized
primary human small intestinal epithelial cells, infected monolayers were processed for trans-
mission electron microscopy following protocol mentioned above.
Toxin secretion assay
LT toxin secretion by different strains was measured using previously established GM1-ELISA
method [81]. Briefly, ELISA plates (Costar, Corning, NY) were coated with 100 μl/well of 1 μg/
ml monosialoganglioside GM1 (Sigma, G-7641), and incubated overnight at RT. After block-
ing with 2% BSA in PBS-Tween, 100 μl of clarified culture supernatant from overnight Luria
broth cultures of bacteria was added to wells in triplicate and incubated for 1 h at 37˚C. The
wells were then washed and incubated with 100 μl of a 1:5000 dilution of rabbit anti-LTB poly-
clonal antisera for 1 h. Plates were again washed and then incubated with 100 μl of a 1:5000
dilution of anti-rabbit secondary conjugated with HRP for another hour. Finally plates were
developed with 100 μL per well of TMB-H2O2 (KPL) substrates and read immediately at
630nm for kinetic measurement (Eon, BioTek instruments, VT, USA).
Cyclic nucleotide assays
Caco-2 cell monolayers grown in 96-well plates were infected with WT or mutant strains and
used to determine alterations in cAMP. After 2 h of infection wells were washed with pre-
warmed tissue culture media, incubated for an additional 2.5 h, cells lysed in sample buffer
and intracellular cAMP concentrations were then determined by ELISA (cAMP Direct EIA,
Arbor Assays, MI, USA). Similarly, T-84 cell monolayers grown in 96-well plates were used to
determine cGMP concentrations following infection. 1.5 h after infection, wells were washed 3
times with pre-warmed tissue culture media, incubated for an additional 3 h, lysed in sample
buffer, and intracellular cGMP determined (cGMP Direct EIA, Arbor Assays, MI, USA).
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Rabbit ileal loop assays
The rabbit ileal loop (RIL) assay was performed as previously described [49, 82]. Briefly, bacte-
ria were grown under static conditions in Luria broth at 37˚C, then washed with PBS, and
diluted yield to a target inoculum of ~1X106 CFU/ml/loop. Adult albino rabbits (New Zealand
strain) weighing 1.5–2.0 kg were fasted for 24 h and allowed only water. Following induction
of anesthesia with intravenous sodium pentobarbital (0.5 mL/kg body mass), the abdominal
cavity was entered, the intestine exposed and the ileum localized. Here, loops of 5 cm in length
were created with surgical ligatures, with 2 cm intervals between each loop to yield 5–6 loops
per rabbit. Loops were then inoculated with either wild type H10407 as a positive control or
mutant strains. Animals were euthanized ~18 h post infection with sodium pentobarbital, the
intestine exposed and the ileocaecal region was then removed. The volume of fluid accumula-
tion determined per unit length of gut within each segment, after which tissue specimens from
the corresponding segment were collected, fixed in formalin (10%), paraffin-embedded and
subsequently processed for examination of villous associated bacteria following protocol men-
tioned above.
Ethics statement
Rabbit ileal loop protocol conducted at icddr,b was reviewed and approved by the institution’s
Animal Experimentation Ethics Committee (AEEC). Experimental procedures were carried
out by veterinarians at the animal facility in accordance with relevant guidelines. The rules and
guidelines followed at icddr,b for animal care and use adhere to the recommendations, with
some modifications, stated in the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health (NIH). These guidelines and the subsequent modifications were
approved by the icddr,b Board of Trustees. All work involving cell lines derived from human
biopsy specimens with the Washington University Digestive Diseases Research Core Center
BioSpecimens Core was performed under a protocol (201406083) approved by the Institu-
tional Review Board at Washington University School Medicine.
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S1 Fig. Type 1 pili mediated ETEC adhesion to epithelial cells. a. Adhesion by wild type (wt)
bacteria or the fimH::Q133K mutant. The percentage of cell associated bacteria represents the
proportion of bacteria associated with the epithelial cells 1 h post infection relative to the inoc-
ulum. b. Adhesion assays of wt, fimA mutant and fimA mutant complemented in trans with
pFimA, or the vector control plasmid. Yeast agglutination phenotypes for the wt and mutant
bacteria are shown below each column of data in the graphs. For data in parts a and b bars rep-
resent the mean. Error bar, SEM (n = 5). P values were calculated by nonparametric Mann-
Whitney test.  represents p<0.01; p<0.05.
(TIF)
S2 Fig. Type 1 pili act in concert with CFA/I fimbriae for optimal adhesion. In vitro adhe-
sion assay to Caco-2 cells infected with either WT H10407 or different mutants, including
fimH and cfaE single mutants or fimH-cfaE double mutants. The percentage of cell associated
bacteria represents the proportion of bacteria associated with Caco-2 cells at the end of 1 h rel-
ative to the inoculum. Different color dots represent data from different experiments, horizon-
tal dashed lines represent geometric mean values. P values were calculated by nonparametric
Mann-Whitney test.  indicates p<0.0001.
(TIF)
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phenicol resistance cassette (chlormaphenicol acetyltransferase; CAT).
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S2 Table. Primers used in this study. p1 and p2 regions are as originally defined by Datsenko,
et al [76]. cat = chloramphenicol acetyl transferase.
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